Document ID: chunk:federal_register_of_legislation:C2015A00089:clause:1_27
Version: federal_register_of_legislation:C2015A00089
Segment Type: clause
Provision Reference: sch 1 cl 27
Character Range: 10482–11386

27  After subsection 99ADB(6)
Insert:
 (6A) The regulations may prescribe information that the method or formula must not take into account (including information that has been provided in compliance with the price disclosure requirements). Information prescribed for the purposes of this section may include information relating to originator brands.
 (6B) The Minister may, by legislative instrument, determine that a brand of a pharmaceutical item that has a drug on F2 is an originator brand.
 (6C) In deciding whether to determine that a brand of a pharmaceutical item is an originator brand, the Minister must have regard to whether, when the brand of the pharmaceutical item was first determined under subsection 85(6):
 (a) the drug in the pharmaceutical item was on F1; or
 (b) subsection 85AB(5) applied to the drug.
 (6D) Subsection (6C) does not apply if the drug is on F2 on 31 March 2016.